The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia

BACKGROUND: Chronic hepatitis C remains a major global health burden with serious long-term consequences if left untreated. Recently the treatment standard of care has shifted to new interferon (IFN)-free drug regimens, which have been shown to be safe and effective. The aim of our study was to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Allister Sebastian, van Driel, Mieke L, Crawford, Darrell HG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633296/
https://www.ncbi.nlm.nih.gov/pubmed/29042803
http://dx.doi.org/10.2147/CEOR.S146280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633296/
https://www.ncbi.nlm.nih.gov/pubmed/29042803
http://dx.doi.org/10.2147/CEOR.S146280

Ejemplares similares